Wegovy-maker Novo Nordisk to cut 9,000 jobs in restructuring

Wegovy-maker Novo Nordisk will cut 9,000 jobs, or about 11.5% of its workforce, in a restructuring to save $1.26 billion annually, it said on Wednesday, as it battles rising pressure from US rival Eli Lilly“Novo Nordisk today announced a company-wide transformation to simplify its organization, improve the speed of decision-making, and reallocate resources towards the company’s growth opportunities in diabetes and obesity,” it said in a statement.The company, which is also known for its Ozempic diabetes tre ...